Alector
Price & Volume
Stats
See more52W Range | $3.49-$8.90 |
Market Cap | $385.8M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $61.5M |
Revenue Growth (YoY) | 68.4% |
Gross Profit (12 Mos) | -$76.8M |
Diluted EPS | -$1.71 |
News
See moreYahoo Finance • 2 months ago
Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024)
Yahoo Finance • 4 months ago
Alector Second Quarter 2024 Earnings: Beats Expectations
Yahoo Finance • 10 months ago
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
Yahoo Finance • 11 months ago
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
About
CEO | Dr. Arnon Rosenthal Ph.D. |
CFO | Dr. Marc Grasso M.D. |
Address | 131 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 241 |
